P

Inventor

ZHENG YIBIN

US48 patents
⚠️ This page may combine multiple inventors who share the name “ZHENG YIBIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

INSULET CORP

37 patents
US11738144B2Aug 29, 2023

Techniques enabling adaptation of parameters in aid systems by user input

INSULET CORP8 citations82
US11547800B2Jan 10, 2023

User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system

INSULET CORP4 citations74
US11957875B2Apr 16, 2024

Techniques and devices providing adaptivity and personalization in diabetes treatment

INSULET CORP2 citations72
US11607493B2Mar 21, 2023

Initial total daily insulin setting for user onboarding

INSULET CORP4 citations72
US11565043B2Jan 31, 2023

Safety constraints for a control algorithm based drug delivery system

INSULET CORP4 citations72
US11324889B2May 10, 2022

Compensation for missing readings from a glucose monitor in an automated insulin delivery system

INSULET CORP2 citations72
US11628251B2Apr 18, 2023

Activity mode for artificial pancreas system

INSULET CORP3 citations70
US12226612B2Feb 18, 2025

Compensation for missing readings from a glucose monitor in an automated insulin delivery system

INSULET CORP1 citations63
US12592306B2Mar 31, 2026

Devices and methods for initialization of drug delivery devices using measured analyte sensor information

INSULET CORP0 citations62
US12551619B2Feb 17, 2026

Automated insulin delivery system using pramlintide

INSULET CORP0 citations62
US12544510B2Feb 10, 2026

Systems and methods for incorporating co-formulations of insulin in an automatic insulin delivery system

INSULET CORP0 citations62
US12496398B2Dec 16, 2025

Threshold based automatic glucose control response

INSULET CORP0 citations62
US12427251B2Sep 30, 2025

User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system

INSULET CORP0 citations62
US12409270B2Sep 9, 2025

Optimizing embedded formulations for drug delivery

INSULET CORP0 citations62
US12370309B2Jul 29, 2025

Adaptive update of automatic insulin delivery (AID) control parameters

INSULET CORP0 citations62
US12343501B2Jul 1, 2025

Techniques to reduce risk of occlusions in drug delivery systems

INSULET CORP0 citations62
US12121701B2Oct 22, 2024

Systems and methods for incorporating co-formulations of insulin in an automatic insulin delivery system

INSULET CORP0 citations62
US11904140B2Feb 20, 2024

Adaptable asymmetric medicament cost component in a control system for medicament delivery

INSULET CORP0 citations62
US11833329B2Dec 5, 2023

Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns

INSULET CORP1 citations62
US11801344B2Oct 31, 2023

Blood glucose rate of change modulation of meal and correction insulin bolus quantity

INSULET CORP1 citations62
US11684716B2Jun 27, 2023

Techniques to reduce risk of occlusions in drug delivery systems

INSULET CORP0 citations62
US11439754B1Sep 13, 2022

Optimizing embedded formulations for drug delivery

INSULET CORP0 citations62
US11935637B2Mar 19, 2024

Onboarding and total daily insulin adaptivity

INSULET CORP1 citations61
US12257420B2Mar 25, 2025

Initial total daily insulin setting for user onboarding

INSULET CORP0 citations60
US11911596B2Feb 27, 2024

Initial total daily insulin setting for user onboarding

INSULET CORP0 citations60
US12433998B2Oct 7, 2025

Activity mode for artificial pancreas system

INSULET CORP0 citations59
US12090301B2Sep 17, 2024

Safety constraints for a control algorithm based drug delivery system

INSULET CORP0 citations59
US11883632B2Jan 30, 2024

Safety constraints for a control algorithm based drug delivery system

INSULET CORP0 citations59
US12496399B2Dec 16, 2025

Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk

INSULET CORP0 citations57
US11986630B2May 21, 2024

Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk

INSULET CORP0 citations57
US12569619B2Mar 10, 2026

Techniques for determining automated insulin delivery dosages

INSULET CORP0 citations52
US12564679B2Mar 3, 2026

Adjusting medicament delivery parameters in an open loop medicament delivery mode

INSULET CORP0 citations52
US12036389B2Jul 16, 2024

Prediction of meal and/or exercise events based on persistent residuals

INSULET CORP0 citations52
US12431229B2Sep 30, 2025

Medicament delivery device with an adjustable and piecewise analyte level cost component to address persistent positive analyte level excursions

INSULET CORP0 citations51
US12406760B2Sep 2, 2025

Exercise safety prediction based on physiological conditions

INSULET CORP0 citations51
US12370307B2Jul 29, 2025

Use of fuzzy logic in predicting user behavior affecting blood glucose concentration in a closed loop control system of an automated insulin delivery device

INSULET CORP0 citations51
US12097355B2Sep 24, 2024

Automatically or manually initiated meal bolus delivery with subsequent automatic safety constraint relaxation

INSULET CORP0 citations38

GEN ELECTRIC

5 patents

LOCKHEED CORP

2 patents

TENCENT TECH SHENZHEN CO LTD

2 patents

ARCAS METECH LTD

1 patent

ZHENG YIBIN

1 patent